By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovaCardia, Inc. 

12230 El Camino Real, Suite 300

San Diego  California  92130  U.S.A.
Phone: n/a Fax:



Start Up

Company News
Merck & Co., Inc. (MRK) Announces Completion of NovaCardia, Inc. Acquisition 9/11/2007 10:09:39 AM
Merck & Co., Inc. (MRK) (Jobs) to Buy NovaCardia, Inc. for $350 Million to Expand Heart Drug Pipeline 7/25/2007 8:11:16 AM
Pilot Phase 3 Results of NovaCardia, Inc.'s KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007 6/11/2007 10:35:47 AM
The Day In Review: Novartis Corporation (NVS) Pulls Zelnorm Off The Market 3/30/2007 5:49:45 PM
NovaCardia, Inc. Files for $86.25 Million IPO 3/30/2007 10:35:32 AM
NovaCardia, Inc. Appoints Joseph L. Turner To Its Board Of Directors 2/6/2007 12:11:24 PM
NovaCardia, Inc. Appoints John E. Crawford As Chief Financial Officer 1/4/2007 12:24:34 PM
NovaCardia, Inc. Presents Phase II Data For KW-3902 At American Heart Association's 79th Annual Scientific Sessions 11/14/2006 12:06:25 PM
NovaCardia, Inc. Raises $48 Million In Series B 9/25/2006 8:43:28 AM
NovaCardia, Inc. Presents Positive Results Of Two Phase II Trials In Late-Breaking Trials Session At Heart Failure 2006 Congress 6/19/2006 11:21:16 AM